Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Fisher

Showing results (181-190 of 190) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 190 results.
British Journal of Cancer|July 21, 2020
Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxiaStephanie G Craig, Matthew P Humphries, Matthew Alderdice, et al.
Clinical Psychology Review|February 8, 2026
Treatment modifiers of interpersonal functioning in psychotherapy for people with borderline personality disorder: Systematic review with meta-analyses of individual participant dataJohanne Pereira Ribeiro, Jutta Stoffers-Winterling, Mie Sedoc Jørgensen, et al.
Lancet (London, England)|June 11, 2017
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trialH Miles Prince, Youn H Kim, Steven M Horwitz, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2021
Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysisYoun H Kim, H Miles Prince, Sean Whittaker, et al.
Psychotherapy and Psychosomatics|October 24, 2025
Treatment Moderators of Symptom Severity in Psychotherapy for People with Borderline Personality Disorder: Systematic Review with Meta-Analyses of Individual Participant DataJohanne Pereira Ribeiro, Jutta Stoffers-Winterling, Mie Sedoc Jørgensen, et al.
Carcinogenesis|November 21, 2015
Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysisAmanda I Phipps, Michael N Passarelli, Andrew T Chan, et al.
JAMA|September 3, 2020
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis, Jonathan A C Sterne, Srinivas Murthy, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2017
Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysisSebastian May-Wilson, Amit Sud, Philip J Law, et al.
Cell|December 16, 2025
HLA export by melanoma cells decoys cytotoxic T cells to promote immune evasionYoav Chemla, Orit Itzhaki, Stav Melamed, et al.
JAMA|July 6, 2021
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis, Manu Shankar-Hari, Claire L Vale, et al.
Pageof 19

Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
British Journal of Cancer|July 21, 2020
Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxiaStephanie G Craig, Matthew P Humphries, Matthew Alderdice, et al.
Clinical Psychology Review|February 8, 2026
Treatment modifiers of interpersonal functioning in psychotherapy for people with borderline personality disorder: Systematic review with meta-analyses of individual participant dataJohanne Pereira Ribeiro, Jutta Stoffers-Winterling, Mie Sedoc Jørgensen, et al.
Lancet (London, England)|June 11, 2017
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trialH Miles Prince, Youn H Kim, Steven M Horwitz, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2021
Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysisYoun H Kim, H Miles Prince, Sean Whittaker, et al.
Psychotherapy and Psychosomatics|October 24, 2025
Treatment Moderators of Symptom Severity in Psychotherapy for People with Borderline Personality Disorder: Systematic Review with Meta-Analyses of Individual Participant DataJohanne Pereira Ribeiro, Jutta Stoffers-Winterling, Mie Sedoc Jørgensen, et al.
Carcinogenesis|November 21, 2015
Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysisAmanda I Phipps, Michael N Passarelli, Andrew T Chan, et al.
JAMA|September 3, 2020
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis, Jonathan A C Sterne, Srinivas Murthy, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2017
Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysisSebastian May-Wilson, Amit Sud, Philip J Law, et al.
Cell|December 16, 2025
HLA export by melanoma cells decoys cytotoxic T cells to promote immune evasionYoav Chemla, Orit Itzhaki, Stav Melamed, et al.
JAMA|July 6, 2021
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis, Manu Shankar-Hari, Claire L Vale, et al.
Pageof 19